Octagon Capital Advisors »

Nkarta shares owned by Octagon Capital Advisors

Quarter-by-quarter ownership of Nkarta (NKTX) shares owned by Octagon Capital Advisors from 13F filings

Historical chart of Octagon Capital Advisors investment in Nkarta

Tip: Access up to 7 years of quarterly data

All positions including Nkarta held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nkarta by Octagon Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.6M 240k 10.81

More positions owned by Octagon Capital Advisors

Apellis Pharmaceuticals Call Option (APLS)
Alpine Immune Sciences (ALPN)
Dianthus Therapeutics (DNTH)
Verona Pharma Sponsored Ads (VRNA)
Dyne Therapeutics (DYN)
Arrivent Biopharma
Insmed Com Par $.01 (INSM)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Eyepoint Pharmaceuticals Com New (EYPT)
Ocular Therapeutix (OCUL)
Structure Therapeutics Sponsored Ads (GPCR)
Bridgebio Pharma (BBIO)
Mind Medicine Mindmed Com New (MNMD)
IsoRay (CATX)
Corbus Pharmaceuticals Hldgs Com New (CRBP)

View all positions for Octagon Capital Advisors

Top funds holding Nkarta

RA Capital Management
Boxer Capital
Deerfield Management Company
Adage Capital Partners GP
Samsara BioCapital
NEA Management Company
Sr One Capital Management
Commodore Capital
BlackRock
EcoR1 Capital
Vanguard Group
T. Rowe Price Investment Management
Cormorant Asset Management
Superstring Capital Management
Daniel D. Thurber

View all funds holding Nkarta